• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.29% Nasdaq Down3.25%

    More On ISIS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Isis Pharmaceuticals, Inc. (ISIS)

    -NasdaqGS
    57.56 0.00(0.00%) Dec 21, 4:00PM EST
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):N/A
    Mean Recommendation (last week):N/A
    Change:N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:N/A
    Median Target:N/A
    High Target:N/A
    Low Target:N/A
    No. of Brokers:N/A

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Nov 18, 2015GoldmanInitiated Neutral
    Nov 5, 2015Piper JaffrayUpgradeNeutralOverweight
    Sep 22, 2015BarclaysInitiated Equal Weight
    Mar 2, 2015StifelDowngradeBuyHold
    Oct 17, 2012Summer Street ResearchDowngradeBuyNeutral
    May 22, 2012NeedhamInitiated Buy
    Mar 26, 2012Canaccord GenuityInitiated Hold
    Aug 5, 2010Collins StewartDowngradeBuyHold
    Aug 5, 2010MP AdvisorsDowngradeOutperformMarket Perform
    Apr 6, 2010Auriga U.S.AInitiated Hold

    More Upgrades & Downgrades for ISIS

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy
    Buy
    Hold
    Underperform
    Sell

    Data provided by Thomson/First Call


    Currency in USD.